{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:27Z","timestamp":1746417747564,"version":"3.40.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Fetal alloimmune thrombocytopenia (FAIT) is a serious life-threatening disease caused by platelet-antigen incompatibility between the mother and fetus. FAIT can lead to fetal thrombocytopenia, intracranial hemorrhage (ICH), fetal death and severe neurological disorders after birth. Noninvasive prenatal diagnosis technology has not been widely used in China, and thus few cases of FAIT can be diagnosed prenatally. In this study, we report a case of prenatal diagnosis and treatment of FAIT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 29-year-old female was admitted at 32 weeks\u2019 gestational age (GA). Fetal ultrasound at 32 weeks\u2019 GA showed a hemorrhagic focus area in the left lateral ventricle and the sign of severe fetal anemia. Hence, fetal umbilical cord puncture was ordered to identify the etiology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The fetal cord blood test revealed a normal hemoglobin level but severe fetal thrombocytopenia (platelet count, 23 \u00d7 10<jats:sup>9<\/jats:sup>\/L). Antibodies of human platelet antigens and human leukocyte antigens between mother and fetus were positive, and thus the diagnosis of FAIT was confirmed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient refused intravenous immunoglobulin (IVIG) therapy owing to financial consideration. She was treated with dexamethasone acetate tablets (Xianju Company, China) 0.75\u200amg twice a day until delivery and cesarean section was performed at 34 weeks\u2019 GA. The newborn received postnatal anti-platelet antibody treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The platelet count of the newborn progressively decreased until the third day after birth and it increased to normal level after postnatal treatment. The neonatal cerebral ultrasound showed the area of hemorrhage was in the process of absorption. During the postnatal one-year follow-up, the neonate showed normal developmental milestones and had no abnormal signs of neurological symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>For FAIT, the fetal umbilical cord puncture can be carried out by skilled fetal medical teams. Dexamethasone acetate tablets can be an alternative choice for patients from underdeveloped areas.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026092","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T14:01:49Z","timestamp":1623938509000},"page":"e26092","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A case report of prenatal diagnosis of fetal alloimmune thrombocytopenia"],"prefix":"10.1097","volume":"100","author":[{"given":"Jing","family":"Fu","sequence":"first","affiliation":[{"name":"Reproductive Medicine Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruojin","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Xiangya Hospital, Central South University, Changsha, Hunan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-2247","authenticated-orcid":false,"given":"Wenjing","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Xiangya Hospital, Central South University, Changsha, Hunan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1471-0528.2010.02657.x","article-title":"Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review","volume":"117","author":"Kamphuis","year":"2010","journal-title":"BJOG"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.2013-3320","article-title":"Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review","volume":"133","author":"Kamphuis","year":"2014","journal-title":"Pediatrics"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1537-2995.2007.01208.x","article-title":"Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/trf.13550","article-title":"Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature","volume":"56","author":"Winkelhorst","year":"2016","journal-title":"Transfusion"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajog.2015.01.059","article-title":"Society for maternal-fetal medicine (SMFM) clinical guideline #8: the fetus at risk for anemia--diagnosis and management","volume":"212","author":"Mari","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/uog.20273","article-title":"Performance of fetal middle cerebral artery peak systolic velocity for prediction of anemia in untransfused and transfused fetuses: systematic review and meta-analysis","volume":"54","author":"Martinez-Portilla","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1537-2995.2008.01748.x","article-title":"External quality assessment of platelet serology and human platelet antigen genotyping: a 10-year review","volume":"48","author":"Porcelijn","year":"2008","journal-title":"Transfusion"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/09537104.2017.1294681","article-title":"Development of quantitative monoclonal antibody-specific immobilization of platelet antigens assay for antibodies against human platelet antigen-1a, 3a, and 5b","volume":"29","author":"Li","year":"2018","journal-title":"Platelets"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1111\/bjh.12235","article-title":"Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management","volume":"161","author":"Peterson","year":"2013","journal-title":"Br J Haematol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.siny.2015.12.004","article-title":"Fetal and neonatal alloimmune thrombocytopenia","volume":"21","author":"Zdravic","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI77820","article-title":"Maternal anti-platelet beta3 integrins impair angiogenesis and cause intracranial hemorrhage","volume":"125","author":"Yougbare","year":"2015","journal-title":"J Clin Invest"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-017-00269-1","article-title":"Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia","volume":"8","author":"Yougbare","year":"2017","journal-title":"Nat Commun"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12958-017-0245-6","article-title":"Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model","volume":"15","author":"Eksteen","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0412.2011.01269.x","article-title":"Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys","volume":"91","author":"Tiller","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R17-20250504","first-page":"1783","article-title":"Effects of antepartum therapy for fetal alloimmune thrombocytopenia on maternal lifestyle","volume":"29","author":"Rossi","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1182\/blood-2010-08-302463","article-title":"Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia","volume":"117","author":"Bertrand","year":"2011","journal-title":"Blood"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:41:37Z","timestamp":1746337297000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026092"}},"subtitle":["A CARE-compliant article"],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":18,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026092","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"2021-03-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}